EM

Eli Mordechai

Director Director DIN 10140138
DIN 10140138 First appointment May 2023 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2023
Shareholding value Locked Premium profile

About Eli Mordechai

Data last updated:

Eli Mordechai has 3 years in corporate governance. Formerly with 1 company, such as Jss Medical Research Asia Pacific Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10140138
Primary Designation Director
First Appointment 02 May 2023
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director02 May 20231999Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jss Medical Research Asia Pacific Private Limited
Premium access

Shareholding and investment profile for Eli Mordechai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Eli Mordechai

Eli Mordechai has 3 years in corporate governance. Formerly with 1 company, such as Jss Medical Research Asia Pacific Private Limited. Engaged in General Business. Contributes to corporate operations.

Eli Mordechai is associated with 0 companies as a director.

Eli Mordechai has expertise in General Business.

Eli Mordechai has 3 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available